18 results
8-K
EX-1.1
INZY
Inozyme Pharma Inc
28 Jul 23
Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock
5:19pm
to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any product
8-K
EX-1.1
INZY
Inozyme Pharma Inc
19 Apr 22
Inozyme Pharma Announces $73 Million Underwritten Offering Priced At-the-Market
7:30am
applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, storage, import, export or disposal of any
S-3
EX-1.2
INZY
Inozyme Pharma Inc
11 Aug 21
Shelf registration
7:12am
, packaging, processing, use, distribution, storage, import, export or disposal of any product manufactured or distributed by them (“Applicable Laws
10-K
eluobnwije3r19 3t9k
25 Mar 21
Annual report
6:21am
10-Q
214paom4
3 Sep 20
Quarterly report
4:19pm
424B4
9yb 2yuzh4nps
24 Jul 20
Prospectus supplement with pricing info
4:01pm
S-1/A
EX-1.1
ypo8dd4egd7h1iqu7zg
20 Jul 20
IPO registration (amended)
6:09am
S-1/A
v6xvaw
20 Jul 20
IPO registration (amended)
6:09am
S-1
3a2o os0h
2 Jul 20
IPO registration
4:02pm
S-1
EX-10.10
k6uerm sw8t1hir2
2 Jul 20
IPO registration
4:02pm
DRS/A
tmmn7pwa26
12 Jun 20
Draft registration statement (amended)
12:00am
DRS
EX-10.10
9m4a ixh1i
8 May 20
Draft registration statement
12:00am
DRS
5o0qx9c yx
8 May 20
Draft registration statement
12:00am
- Prev
- 1
- Next